Log in to save to my catalogue

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular ca...

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7653936

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

About this item

Full title

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2020-11, Vol.123 (10), p.1521-1534

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
High probability of metastasis limited the long-term survival of patients with hepatocellular carcinoma (HCC). Our previous study revealed that Galectin-3 was closely associated with poor prognosis in HCC patients.
Methods
The effects of Galectin-3 on tumour metastasis were investigated in vitro and in vivo, and the underlying b...

Alternative Titles

Full title

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7653936

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7653936

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/s41416-020-1022-4

How to access this item